Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Autosomal dominant mutations in the SFTPC gene are associated with idiopathic pulmonary fibrosis, a progressive lethal interstitial lung disease. Mutations that cause misfolding of the encoded proprotein surfactant protein C (SP-C) trigger endoplasmic reticulum (ER)-associated degradation, a pathway that segregates terminally misfolded substrate for retrotranslocation to the cytosol and degradation by
proteasome
. Microarray screens for genes involved in SP-C ER-associated degradation identified
MKS3
/TMEM67, a locus previously linked to the ciliopathy Meckel-Gruber syndrome. In this study,
MKS3
was identified as a membrane glycoprotein predominantly localized to the ER. Expression of
MKS3
was up-regulated by genetic or pharmacological inducers of ER stress. The ER lumenal domain of
MKS3
interacted with a complex that included mutant SP-C and associated chaperones, whereas the region predicted to encode the transmembrane domains of
MKS3
interacted with cytosolic p97. Deletion of the transmembrane and cytosolic domains abrogated interaction of
MKS3
with p97 and resulted in accumulation of mutant SP-C proprotein; knockdown of
MKS3
also inhibited degradation of mutant SP-C. These results support a model in which
MKS3
links the ER lumenal quality control machinery with the cytosolic degradation apparatus.
...
PMID:Meckel-Gruber syndrome protein MKS3 is required for endoplasmic reticulum-associated degradation of surfactant protein C. 1981 49